106 related articles for article (PubMed ID: 7903944)
1. A high dose of EEDQ reduces pituitary dopamine D2 receptor density and the prolactin suppressive potency of agonists.
Ekman A; Eriksson E
Eur J Pharmacol; 1993 Oct; 243(3):295-9. PubMed ID: 7903944
[TBL] [Abstract][Full Text] [Related]
2. Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.
Ekman A; Eriksson E
Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):152-7. PubMed ID: 1360151
[TBL] [Abstract][Full Text] [Related]
3. Effects of the two partial D2 agonists (+)- and (-)-3-PPP on prolactin release in EEDQ treated male rats.
Ekman A; Quiding M; Eriksson E
Life Sci; 1991; 48(4):311-20. PubMed ID: 1671291
[TBL] [Abstract][Full Text] [Related]
4. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
Ekman A; Eriksson E
Life Sci; 1991; 48(4):321-31. PubMed ID: 1824955
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Cox RF; Waszczak BL
Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
[TBL] [Abstract][Full Text] [Related]
6. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
7. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Cox RF; Waszczak BL
Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
[TBL] [Abstract][Full Text] [Related]
8. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
Meller E; Puza T; Miller JC; Friedhoff AJ; Schweitzer JW
J Pharmacol Exp Ther; 1991 May; 257(2):668-75. PubMed ID: 1674531
[TBL] [Abstract][Full Text] [Related]
9. Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfected clonal cell line (GH4ZR7).
Nilsson C; Eriksson E
Eur J Pharmacol; 1992 Aug; 218(2-3):205-11. PubMed ID: 1358634
[TBL] [Abstract][Full Text] [Related]
10. The effects of pertussis toxin on dopamine D2 and serotonin 5-HT1A autoreceptor-mediated inhibition of neurotransmitter synthesis: relationship to receptor reserve.
Bohmaker K; Bordi F; Meller E
Neuropharmacology; 1992 May; 31(5):451-9. PubMed ID: 1356248
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats.
Matsumoto S; Yamada K; Nagashima M; Domae M; Shirakawa K; Furukawa T
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):21-5. PubMed ID: 2571944
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
Lévesque D; Di Paolo T
Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
[TBL] [Abstract][Full Text] [Related]
13. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
Cox RF; Waszczak BL
Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
[TBL] [Abstract][Full Text] [Related]
14. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
Crawford CA; Rowlett JK; McDougall SA; Bardo MT
Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
[TBL] [Abstract][Full Text] [Related]
16. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
Giorgi O; Biggio G
Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
[TBL] [Abstract][Full Text] [Related]
17. Ontogenetic differences in the effects of EEDQ on dopamine-mediated behaviors.
Mestlin M; McDougall SA
Pharmacol Biochem Behav; 1993 Aug; 45(4):797-802. PubMed ID: 8105488
[TBL] [Abstract][Full Text] [Related]
18. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
Meller E; Bohmaker K; Namba Y; Friedhoff AJ; Goldstein M
Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats.
Der-Ghazarian T; Gutierrez A; Varela FA; Herbert MS; Amodeo LR; Charntikov S; Crawford CA; McDougall SA
Neuroscience; 2012 Dec; 226():427-40. PubMed ID: 23000622
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of dopamine receptor inactivation during the adolescent period: age-dependent changes in dorsal striatal D2(High) receptors.
McDougall SA; Valentine JM; Gonzalez AE; Humphrey DE; Widarma CB; Crawford CA
Psychopharmacology (Berl); 2014 Apr; 231(8):1637-47. PubMed ID: 24287603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
